NCT02055586View on ClinicalTrials.gov

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

October 22, 2013

Primary Completion Date

November 27, 2017

Study Completion Date

December 27, 2017

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
OTHER

fluorine F 18 fluorothymidine

Undergo FLT-PET/MRI

DEVICE

positron emission tomography

Undergo FLT-PET/MRI

DEVICE

magnetic resonance imaging

Undergo FLT-PET/MRI

Trial Locations (1)

44106-5065

Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT02055586 - FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents | Biotech Hunter | Biotech Hunter